Smt Cardiovascular Private Limited, a active private limited company, was established on 16 November 2019 in Surat, Gujarat, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U33302GJ2019PTC110835. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.24 M.
It upholds a compliant status. Employing 104 professional, Its leadership includes Ganesh Prasad Sabat (Director), Bhargav Dhirajlal Kotadia (Director), Sonalika Dhar (Director). Past directors included Sonalika Dhar. It holds ₹147.64 Cr open charges and no settled loans. Its latest AGM occurred on 11 July 2025, with the balance sheet filed on 31 March 2025. It is based at Sahajanand Estate, Wakharia Wadi, Near Dabholi Char Rasta, Nani Ved, Ved Road,, Surat, Gujarat, 395004.
U33302GJ2019PTC110835
110835
16 November 2019
₹0.50 M
₹0.24 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Smt Cardiovascular Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesh Prasad Sabat | Director | 16 Nov 2019 | Current |
| Bhargav Dhirajlal Kotadia | Director | 16 Nov 2019 | Current |
| Sonalika Dhar | Director | 29 May 2025 | Current |
| Ajit Ramkrishna Bhawar | Additional Director | 12 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 10 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Smt Cardiovascular Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16006.7% increase. The company also saw a substantial fall in profitability, with a 105.9% decrease in profit. The company's net worth Soared by an impressive increase of 170.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Smt Cardiovascular had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,476,370,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2024 | Others | ₹2.50 Cr | Open |
| 15 Apr 2024 | Others | ₹45.14 Cr | Open |
| 13 Apr 2020 | Standard Chartered Bank | ₹100.00 Cr | Open |
Explore comprehensive loan charge details -
Smt Cardiovascular has a workforce of 104 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Smt Cardiovascular, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smt Cardiovascular's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ajit Ramkrishna Bhawar was appointed as a Additional Director was appointed as a Additional Director on 12 Aug 2025 & has been associated with this company since 4 months 2 days . was completed.
The activity Smt Cardiovascular Private Limited last Annual general meeting of members was held on 11 Jul 2025 as per latest MCA records. was completed.
The activity Sonalika Dhar was appointed as a Director was appointed as a Director on 29 May 2025 & has been associated with this company since 6 months 16 days . was completed.
The activity Smt Cardiovascular Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
A charge with Others amounted to Rs. 25.00 M with Charge ID 101014668 was registered on 05 Dec 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 451.37 M with Charge ID 100954287 was registered on 15 Apr 2024. was recorded as a recent event.
SMT invests 250 Cr in Telangana for medical device unit. KTR happy. SMT makes stents and catheters, creates jobs. Founded in 2001, supports 'Make in India'. Biggest in India, exports to 60+ countries. Has plant in Gujarat and R&D centers. First to get CE certification for drug-eluting stent. Customer-focused and sells directly..
Indian stent Supraflex confirmed as good as global standard Xience in TALENT study. Supraflex made by SMT, Indian company specializing in life-changing vascular solutions. Study conducted in 7 countries with 1435 patients. Supraflex has better efficacy and lower re-procedure rate. Available in 65 countries, largest selling stent in India. Advanced features like biodegradable polymer and ultra-thin struts. TALENT results match published meta-analysis. CEO proud of India's success in life-saving technology industry. Over 5,00,000 stents used in India every year. Drug eluting stents help prevent artery narrowing after surgery..
The CIN of Smt Cardiovascular Private Limited is U33302GJ2019PTC110835.
Smt Cardiovascular Private Limited is headquartered at Sahajanand Estate, Wakharia Wadi, Near Dabholi Char Rasta, Nani Ved, Ved Road,, Surat, Gujarat, 395004.
Smt Cardiovascular Private Limited was incorporated on 16 November 2019.
The current directors of Smt Cardiovascular Private Limited are
The primary industry of Smt Cardiovascular Private Limited is Manufacturing.
Smt Cardiovascular Private Limited is unlisted.
The authorized capital of Smt Cardiovascular Private Limited is ₹0.50 M, and the paid-up capital is ₹0.24 M.
The compliance status of Smt Cardiovascular Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX